The Global Market for Apheresis Equipment is Projected to Reach US$2.2 Billion by 2020

Growth in Global Blood Supply Fuels Demand for Apheresis Equipment, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Apheresis Equipment. The global market for Apheresis Equipment is projected to reach US$2.2 billion by 2020, driven by the growth in global blood supply, against a backdrop of aging population and rising prevalence of diseases requiring blood transfusion.

Apheresis is a process wherein blood from a person (patient or donor) is passed through a medical device to extract the required components through centrifugation or membrane filtration technologies, and later returned to circulation with or without extracorporeal treatment. Apheresis process is used either for donation of blood (donor apheresis) or for therapeutic treatment (therapeutic apheresis). Rising prevalence of blood disorders such as sickle cell anemia, blood cancer, and hemophilia will help drive growth in demand for apheresis equipment. Other factors driving growth in the market include escalating demand for plasma from biopharmaceutical companies for use in plasma fractionation, new establishment of community blood centers, and increased investments in blood and blood component collection equipment. The growing adoption of apheresis equipment is largely attributable to the numerous benefits offered by the technology such as, reduced risk of allogeneic-donor exposures & transfusion complications among recipient patients, cost efficiency, and benefits in patient management. The growing demand for safe blood among hospitals and patients will therefore spur growth in investments in apheresis equipment.

The key factors driving growth in the donor apheresis market include rising awareness over the safety of blood donation through apheresis, and growing number of platelet donations (Platelet Apheresis), plasma donations (Plasma Apheresis), leukocytes donation (Leukapheresis) and double red cell donation, among others. Donor apheresis procedures are growing in popularity driven by their advantages over whole blood collection. Demand for therapeutic apheresis, on the other hand, is fuelled by the increasing use of apheresis in the treatment of cancer and autoimmune disorders. Expanding application of therapeutic apheresis in treating circulatory disorders caused by excess blood proteins is also benefiting the market. In the coming years, new avenues for therapeutic apheresis will emerge from the Pediatrics sector, given the huge unmet medical needs among infants and children.

As stated by the new market research report on Apheresis Equipment, the United States represents the largest market worldwide, supported by high patient awareness, well-established healthcare infrastructure, supportive reimbursement policies and availability of advanced blood collection technologies. Asia-Pacific is forecast to emerge as the fastest growing market with a projected CAGR of 12% over the analysis period. Growth in the region is led by rising incidence of disease and sickness among the growing population, government focus on healthcare infrastructure development, easy access to affordable healthcare, increasing number of government licensed and accredited blood banks, launch of numerous new voluntary blood donation camps and higher healthcare spends among the growing base of affluent middle class population.

Major players covered in the report include Asahi Kasei Medical Co. Ltd., B Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Fenwal Inc., Haemonetics Corporation, HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, NIKKISO Europe GmbH, Terumo BCT Inc., and Therakos Inc., among others.

The research report titled “Apheresis Equipment: A Global Strategic Business Report”, announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for all major geographic markets including the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Product segments analyzed in the report include Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis. Also analyzed are apheresis equipment by procedure type including Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others.